Engineering & Urology Society - 34th Annual Meeting "Found in Translation"

The Engineering and Urology Society holds its 34th Annual Meeting: “Found in Translation”, on Sunday, May 5^th in Chicago. The mission of the Engineering and Urology Society, a subsection of the Endourological Society, is to promote the development and application of new technology in urology through facilitating collaboration between engineers, physicists, and urologists.

Jaime Landman, M.D. and Zhamshid Okhunov, M.D. (meeting co-chairs) from the University of California, Irvine have organized a unique opportunity to better understand advanced contemporary urologic technologies and the process of successful technology development as presented by world class urologist and biotechnology industry leaders. Lectures on the thulium fiber laser, MRI fusion imaging, aquablation, applications of novel simulation technologies and role of artificial intelligence and machine learning in Urology will be presented. Expert lectures will be delivered on next generation approaches for urologic tissue repair and regeneration in lower urinary tract disease. Two keynote lectures will be presented: Dr. Ralph Clayman will review the role of immersive virtual reality as a disruptive technology in management of stones, renal masses and transplant surgery, and Dr. Peter Chang, co-director of the UCI Center for AI and Machine Learning, will review the role of AI and machine learning in urology today and in the future. Finally, for the first time in the history of the meeting, a CEO Roundtable, including 5 globally prominent CEO/Chair leaders (Dr. Arie Belldegrun, Dr. Ralph Clayman, Dr. Fred Moll, Mr. Abel Ang and Mr. Kurt Azabarzin) who have each had a major role in transforming urology via translational engineering, will share their experiences overcoming challenges in translation and delivering products from bench to bedside.

Two poster sessions in the afternoon provide researchers with the opportunity to present their work and update the attendees on the progress on the field and the latest innovations. The review of the abstracts for the poster sessions was performed online by a group of 47 reviewers from around the world. Each paper received between 11 and 13 reviews. We would like to thank the reviewers, listed at the end of this program book, for their essential contribution to the quality of the meeting and their constructive comments that they made for the research.

Based on the review scores, the Society presents the Best Paper Awards to “Intraoperative Guidance for Robotic Partial Nephrectomy using Surface-Based Registration: Initial Model Assessment” from the Department of Mechanical Engineering and Department of Urologic Surgery at Vanderbilt University, Nashville, TN and “Improving Prostate Cancer Margins Prediction with Machine Learning” from Avenda Health, Inc, Santa Monica, CA and David Geffen School of Medicine, UCLA, Los Angeles, CA. This is listed at the end of this program book, together with the Top 10 abstracts, and Best Reviewer Awards. The authors of all awarded abstracts are invited to submit full length articles to the Journal of Endourology on the respective topics. We gratefully thank all reviewers for their hard work, objective scoring, and contribution to the success of the meeting.

We welcome all urologists, engineers, and scientists to join us for this unique cross-disciplinary experience. As always, we thank Dr. George Nagamatsu the founder and first president of the society, and Dr. Jack Vitenson the first Society Treasurer for setting up the foundations based upon which we meet.

Program: Engineering and Urology Society - 34th Annual Meeting: “Found in Translation” Sunday, May 5^th in Chicago, IL
A complete version of this program including the abstracts presented.
7:00am	Registration
7:50am – 8:00am	Welcome

Jaime Landman, MD Professor of Urology and Radiology, Chairman, Department of Urology, University of California Irvine
Zhamshid Okhunov, MD Endourology Fellow, Department of Urology, University of California Irvine
8:00am –9:30am	The Disruptors and Translational Success
8:00 – 8:15 Gregory Altshuler, PhD; President, IPG Medical Corporation	Lasers in Urology: The Role of Thulium Fiber Lasers
8:15 – 8:30 Peter Pinto, MD; Professor of Urology, National Cancer Institute	MRI Fusion Imaging: Past, Present and Future
8:30 – 8:45 Nikolai Aljuri, President and CEO, PROCEPT Biorobotics	Aquablation: A Transformative Ablation
8:45 – 9:00 Mihir Desai, MD Professor of Urology, Department of Urology, University of Southern California, Keck School of Medicine	State of the Art Robotics
9:00 – 9:15 Robert Sweet, MD Professor of Urology, University of Washington, Seattle	Simulation in Urology: Where We Are And Where Are We Going
9:15 – 9:30 Ralph Clayman, MD Professor of Urology, Dean Emeritus, Department of Urology, University of California, Irvine	iVR: A Disruptive Technology
9:30am –10:00am	Artificial Intelligence and Machine Learning
9:30 – 10:00 Peter Chang, MD Director, Center of Artificial Intelligence in Diagnostic Medicine, University of California, Irvine	Artificial Intelligence & Machine Learning in Urology: Present and Future
10:00am – 10:30am	Next Generation Approaches for Urologic Tissue Repair and Regeneration
10:00 – 10:15 Joshua Mauney, MD Assistant Professor of Surgery, Department of Urology, Harvard Medical School	Surgical and Pharmacological Breakthroughs in the Management Of Obstructive Bladder Disease
10:15 – 10:30 Trinity Bivalacqua, MD Professor, Director of Urologic Oncology, James Buchanan Brady Urologic Institute, Johns Hopkins University	Surgical and Biomaterial Advances for Regeneration of the Lower, Urinary Tract
10:40am – 12:00pm	CEO/Chair Roundtable: The Real Transformers Overcoming Challenges in Translation
1. Kurt Azabarzin, Vice President of R&D, CONMED Corporation
2. Abel Ang, Chief Executive Officer, Dornier MedTech
3. Fred Moll, Chairman and Chief Executive Officer, Auris Health, Inc.
4. Ralph Clayman, MD; Professor of Urology, Dean Emeritus, Department of Urology, University of California, Irvine
5. Arie Belldegrun, MD; Professor of Urology, University of California, Los Angeles, Chairman, UroGen Pharma, Inc.
6. Questions and answers with the CEO/Chairs

Meet the Real Transformers

Coming Soon: Engineering & Urology Society at the AUA - What to Expect with Jaime Landman

Login